The intersection of science and commercial enterprise
While GRA capitalizes on opportunities to recruit scientists and seed commercial ventures, our investments have a strategic focus. This is to ensure that Georgia has a concentration of talent and enterprises in a number of defined areas.
Such concentration brings benefits. The likelihood for collaboration increases; the appeal to prospective funding sources is made more compelling; the potential to create critical mass becomes real.
GRA’s strategic focus now encompasses nine intersections of science and industry (below). Explore the work of GRA Eminent Scholars or visit the websites of companies in these areas. Or access a complete list of companies recently seeded and shaped by GRA Ventures, the commercialization program of GRA.
Agricultural Science and GenomicsTwo GRA Eminent Scholars, one company
Body Surface Translations
Biomedical Engineering and Regenerative MedicineFive GRA Eminent Scholars, 9 companies, 1 project
Amniox Medical Inc.
Apica Cardiovascular Technologies
APK Advanced Medical Technologies
Project: Dx/Rx Device for Autism
Cancer and Human GenomicsSeven GRA Eminent Scholars, 33 GRA Cancer Scientists, two companies
Sisene Oncology, LLC
Computing and NetworksSix GRA Eminent Scholars, 11 companies
Biing "Fred" Juang
Velocity Medical, Inc.
Electronics and OpticsSeven GRA Eminent Scholars, 10 companies
Jiri (Art) Janata
Energy and Environmental EngineeringSix GRA Eminent Scholars, 4 companies, 1 project
C. J. Tsai
Project: Garimella Cooling
Immunology and VaccinesThirteen GRA Eminent Scholars, 1 company
Informatics and Systems BiologyEight GRA Eminent Scholars, 2 companies
Peng George Wang